NaseemAJaffraniMDFACC, FSCAI

PubMed

• An Inclisiran First Strategy vs Usual Care in Patients with Atherosclerosis.
  Peter P Toth, Cheryl A Abbas, Samiha Sarwat, Kelly Kleeman, Biswajit Kumar, Yousuf Ali, Michael J Koren, Fatima Rodriguez, Cara East, Veena Watwe, Naseem Jaffrani> ;Journal of the American College of Cardiology. 2024 Apr 1
• Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLO...
  Ding WY, Fawzy AM, Romiti GF, Proietti M, Pastori D, Huisman MV, Lip GYH, GLORIA-AF Investigators> ;Journal of thrombosis and thrombolysis. 2023-08-11
• 1 citations
  Efficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function.
  Alex D Hakim, Mustafa Awili, Hollis R O'Neal, Omar Siddiqi, Naseem Jaffrani, Richard Lee, Jeffrey S Overcash, Ann Chauffe, Terese C Hammond, Bela Patel, Michael Waters...> ;Clinical and Experimental Immunology. 2023 Oct 13
• Cardiovascular Safety of Testosterone-Replacement Therapy.
  Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM, Wang Q, Wolski K, Davey D, Kalahasti V, Khan N, Mi...> ;The New England journal of medicine. 2023-06-16
• Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.
  Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, Baker J, Pérez Marc G, Radley D, Shittu E, Glanternik J, Snaggs H, Baber J, Zachariah P, Barnabas SL, F...> ;The New England journal of medicine. 2023-04-05
• Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial.
  Waters M, McKinnell JA, Kalil AC, Martin GS, Buchman TG, Theess W, Yang X, Lekkerkerker AN, Staton T, Rosenberger CM, Pappu R, Wang Y, Zhang W, Brooks L, Cheung D, Gal...> ;Critical care medicine. 2022-11-14
• Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
  Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Gin...> ;The New England journal of medicine. 2022-11-05
• 9 citations
  Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis of a P...
  Kieran F. Docherty, Pardeep S. Jhund, Brian Claggett, João Pedro Ferreira, Olof Bengtsson, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Fel...> ;JAMA Cardiology. 2021 Nov 1
• Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
  Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg...> ;Journal of the American College of Cardiology.
• Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
  Pfeffer MA, Claggett B, Lewis EF, Granger CB, Køber L, Maggioni AP, Mann DL, McMurray JJV, Rouleau JL, Solomon SD, Steg PG, Berwanger O, Cikes M, De Pasquale CG, East ...> ;The New England journal of medicine.
• Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Pres...
  Pieske B, Wachter R, Shah SJ, Baldridge A, Szeczoedy P, Ibram G, Shi V, Zhao Z, Cowie MR, PARALLAX Investigators and Committee members> ;JAMA.
• Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
  Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Marler S, Gurusamy VK, Huisman MV, GLORIA-AF Investigators> ;Clinical research in cardiology : official journal of the German Cardiac Society.
• Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
  Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R...> ;Circulation. 2022-06-30
• Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.
  Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Marler S, Gurusamy VK, Huisman MV, GLORIA-AF Investigators> ;Clinical research in cardiology : official journal of the German Cardiac Society. 2022-03-16
• 22 citations
  Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a po...
  Subodh Verma, Nitish K. Dhingra, Javed Butler, Stefan D. Anker, João Pedro Ferreira, Gerasimos Filippatos, James L. Januzzi, Carolyn S.P. Lam, Naveed Sattar, Barbara P...> ;The Lancet. Diabetes & Endocrinology. 2021 Nov 30
• Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
  Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, Dhingra NK, Ketchum SB, Juliano RA, Jiao L, Doyle RT, Granowitz C, Gibson CM, Pinto D, Giugliano RP, Bud...> ;Circulation. 2021-10-28
• Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
  Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K, AMPLITUDE-O Trial Investig...> ;The New England journal of medicine. 2021-06-28
• Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV Trial.
  Cherney DZI, Cosentino F, Dagogo-Jack S, McGuire DK, Pratley R, Frederich R, Maldonado M, Liu CC, Liu J, Pong A, Cannon CP, VERTIS CV Investigators> ;Clinical journal of the American Society of Nephrology : CJASN. 2021-06-18
• Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US.
  Cannon CP, de Lemos JA, Rosenson RS, Ballantyne CM, Liu Y, Gao Q, Palagashvilli T, Alam S, Mues KE, Bhatt DL, Kosiborod MN, GOULD Investigators> ;JAMA cardiology. 2021-06-16
• Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.
  Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG, ODYSSEY OUTCOMES Committees and Investigators> ;Diabetes care. 2021-03-15
• 1 citations
  Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry
  George Ntaios, Menno V. Huisman, Hans-Christoph Diener, Jonathan L. Halperin, Christine Teutsch, Sabrina Marler, Venkatesh K. Gurusamy, Milla Thompson, Gregory Y.H. Li...> ;Hellenic Journal of Cardiology. 2021 Mar 1
• Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure.
  Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD, Adams KF, Anand I, Arias-Mendoza A, Biering-Sørensen T, Böhm M, Bonderman D, Cleland JGF, Corbalan R...> ;The New England journal of medicine. 2020-11-13
• 4 citations
  Therapeutic approach to unstable angina : nitroglycerin, heparin, and combined therapy
  Naseem A Jaffrani, Seymour Ehrenpreis, Atul Laddu, John C. Somberg> ;American Heart Journal. 1993 Nov 1
• Join now to see all